Assembly Biosciences (ASMB) FCF Margin Growth (1y) (2018 - 2026)
Assembly Biosciences (ASMB) FCF Margin Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1,187.00 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1,525.00 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -341.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Assembly Biosciences | 431.63 Mn | 205.03 Mn | - | -2,043.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2,043.00 |
| Dec 31, 2025 | 3,900.00 |
| Sep 30, 2025 | 8,205.00 |
| Jun 30, 2025 | 2,649.00 |
| Mar 31, 2025 | 6,884.00 |
| Dec 31, 2024 | -104,431.00 |
| Sep 30, 2021 | -39,154.00 |
| Dec 31, 2020 | -200,580.00 |
| Sep 30, 2020 | 55,061.00 |
| Jun 30, 2020 | 61,878.00 |
| Mar 31, 2020 | -4,461.00 |
| Dec 31, 2019 | 2,255.00 |
| Sep 30, 2019 | -12,485.00 |
| Jun 30, 2019 | -18,150.00 |
| Mar 31, 2019 | -13,798.00 |
| Dec 31, 2018 | -14,785.00 |
| Sep 30, 2018 | 4,072.00 |
| Jun 30, 2018 | 2,231.00 |
| Mar 31, 2018 | -554,369.00 |